Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?
about
Nicotine receptor partial agonists for smoking cessationNicotine receptor partial agonists for smoking cessationNon-psychotropic medication and risk of suicide or attempted suicide: a systematic reviewVarenicline as a Cause of Suicidal OutcomesHow complete are E-codes in commercial plan claims databases?Selective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort StudyThe statistics of suicide.Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental studyReporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011.Modelling cognitive affective biases in major depressive disorder using rodents.Pediatric inflammatory bowel disease and depression: treatment implications.Varenicline, smoking cessation, and neuropsychiatric adverse events.Antidepressant treatment and suicide attempts and self-inflicted injury in children and adolescents.Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene InhibitorsImpact of varying outcomes and definitions of suicidality on the associations of antiepileptic drugs and suicidality: comparisons from UK Clinical Practice Research Datalink (CPRD) and Danish national registries (DNR).Getting through the quicksand of the relationship between drugs and suicide.Variation in the 12-Month Treatment Trajectories of Children and Adolescents After a Diagnosis of Depression.
P2860
Q24185773-2D4F92B3-5A41-4E1C-841A-52C6FC568130Q24200322-37518E4A-05BD-45B5-A26E-E6BFC185BB51Q28078315-57F97912-BC20-40FF-BB8B-2C8D28419A95Q28255130-5E910DC3-F87F-4119-936C-5F730BE42682Q28390387-3908E85E-4554-4744-AA88-D59EA91B19C3Q28548023-2AACE58B-C9CA-40CE-9A28-32F3D39138E8Q33744415-B71BD31F-A4DD-428B-9633-FDBED65A99CAQ33774659-C9F29BB0-9DAE-4648-A38E-6ECCB80B1B90Q34285010-5E6FFAAA-B0C3-4AEA-A59B-886EA62AC5B6Q34349717-6E2B98D5-CD05-43DD-98BC-9C90571160CBQ34498319-56A77DD6-9FBA-441A-B4A2-B1420A6F4071Q34546833-FD2164F6-3E1C-4D33-9890-C70C90913799Q35032482-EFA48D60-A4C2-4CBC-B9C6-5604503BC802Q37402764-3CB2006C-5410-40E9-86FF-21C743C5D61FQ39869497-B9893E0A-AC25-4FB8-95FF-D57404FBF024Q45212421-32C2E10E-50E5-40EA-9775-F6ACFB83F50FQ47438099-37C5DE56-37BE-4348-9E46-D1D05F07FC5A
P2860
Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Strategies for quantifying the ...... aviour: what has been learned?
@en
Strategies for quantifying the ...... aviour: what has been learned?
@nl
type
label
Strategies for quantifying the ...... aviour: what has been learned?
@en
Strategies for quantifying the ...... aviour: what has been learned?
@nl
prefLabel
Strategies for quantifying the ...... aviour: what has been learned?
@en
Strategies for quantifying the ...... aviour: what has been learned?
@nl
P2860
P921
P1433
P1476
Strategies for quantifying the ...... aviour: what has been learned?
@en
P2093
J John Mann
Robert D Gibbons
P2860
P304
P356
10.2165/11589350-000000000-00000
P577
2011-05-01T00:00:00Z
P6179
1027661842